Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07177235 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ketamine for the Treatment of Refractory Status Epilepticus

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This pilot feasibility study aims to examine how the timing of ketamine introduction as a third-line anti-seizure medication infusion relates to seizure cessation in patients with refractory status epilepticus (RSE).
Trial Details
NCT Number NCT07177235
Lead Sponsor Thomas Jefferson University
Conditions
(from sponsor)		 Refractory Status Epilepticus
Related terms Status Epilepticus
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov